Caristo Diagnostics
Generated by Meeveem AI
"AI-powered cardiac inflammation detection that predicts heart attacks a decade in advance"
Oxford
•51 - 250 Employees
•Digital Health
About Caristo Diagnostics
Caristo Diagnostics transforms heart attack prevention through CaRi-Heart® technology, an AI-powered platform that detects hidden coronary inflammation from standard cardiac CT scans. For over 50 years, clinicians have known inflammation causes heart attacks but lacked tools to visualise it. CaRi-Heart® fills this gap, predicting cardiac events up to 10 years in advance. The technology enables personalised treatment through comprehensive risk assessment. Patients at high risk receive early intervention, while those at low risk avoid unnecessary procedures. With regulatory approvals in Europe, the UK, Australia, and the US, Caristo serves healthcare providers, pharmaceutical companies, and preventive health clinics reducing cardiovascular mortality.
60
Team Members
2018
Founded
Digital Health
Sector
On-Site
Work Environment
Our Vision
A world where heart attacks are prevented through early detection of coronary inflammation, where personalised cardiac care saves lives decades before symptoms appear, and cardiovascular disease ceases to be the leading cause of death.
Our Mission
Caristo is committed to transforming health outcomes through clinical and scientific innovation.